Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,251.8
11.1 (0.34%)

 

  • STI Straits Times Index
    3,251.8
    11.1 (0.34%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,606.7
    -3.0 (-0.19%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,922.0
    -4.6 (-0.02%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,903.5
    -6.5 (-0.22%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,370.2
    38.3 (0.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,137.0
    -11.7 (-0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,126.1
    2.0 (0.09%)
    Index delayed 20 minutes
  • XAO XAO
    6,844.9
    -32.1 (-0.47%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 460.6M
  • Value: 335.0M
  • Rise: 132
  • Fall: 83
  • Unch: 613

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.191-0.008
Tritech0.027+0.007
Golden Agri-Res0.240+0.010
MarcoPolo Marine0.021-0.001
GSS Energy0.104+0.001
Koh Eco0.058+0.001
Alpha Energy0.036-
Ley Choon0.018+0.002
Addvalue Tech0.024+0.001
Jiutian Chemical0.016+0.001

World Indices

World Indices
Name Last Change
Nasdaq 8,464.3 -11.0
HSI 26,841.8 -84.7
HSCEI 10,605.9 -7.8
Jakarta 6,139.1 -9.7
Nikkei 225 23,370.2 +38.4
SSE Comp 2,895.1 -14.9
Shanghai A 3,033.1 -15.6
Shanghai B 258.2 -1.6
PSE Comp 0.0
KOSPI 2,126.4 +2.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

LINEAGE CELL THERAPEUTICS INC LINEAGE CELL THERAPEUTICS INC
Updated on 11 Nov 2019 (End of trading day)
Last (USD): 0.730 Change: -0.066 High: 0.839 Remarks: -
Change (%): -8.33 Low: 0.724
Open 0.839 Yesterday's Close 0.7962
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 543,011 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.30733 Trailing EPS (USD) e 0.20750 NAV (USD) b 0.8914
PE a - Trailing PE f 3.518 Price / NAV b 0.8188
Dividend (USD) d - Cash In Hand (USD) g 0.0549 Issued & Paid-up Shares c 149,643,000
Dividend Yield (%) d - Price / Cash In Hand g 13.295 Treasury Shares h -
Beta - 75 Daysi 1.479 R-Squared - 75 Days(%)i 12.05 Market Cap (M) 109.224
Beta - 500 Daysi 1.478 R-Squared - 500 Days (%)i 12.05 Enterprise Value (M) 95.783
Piotroski F Score 0 Exchange Code LCTX Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 98.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Sep 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Aug 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference LINEAGE CELL THERAPEUTICS INC NYSE American 109.224 - 3.518 0.8188 -
Industry Biotechnology NYSE American 71.172 - - 3.5744 -
Local Peer PFENEX INC NYSE American 245.878 - - - -
Local Peer 22ND CENTURY GROUP INC NYSE American 161.333 - - - -
Local Peer NANOVIRICIDES INC NYSE American 128.036 - - 12.0833 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 118.898 - - - -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 124.534 3.481 3.481 1.2386 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 83.235 - - 2.7023 -
Local Peer CEL-SCI CORP NYSE American 64.418 - - 56.1889 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 54.030 - - 526.6250 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 44.455 - - 1.9644 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 26.903 - - - -
Local Peer ORAGENICS INC NYSE American 23.085 - - 1.2889 -
Local Peer ACTINIUM PHARMACEUTICALS INC NYSE American 20.013 - - 1.2747 -
Other Local Peers ISORAY INC (NYSE American), IBIO INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AIM IMMUNOTECH INC (NYSE American)
Global Peer AMGEN INC NASDAQ 131,136.409 15.623 16.256 12.0012 2.535
Global Peer GILEAD SCIENCES INC NASDAQ 81,779.296 14.992 30.367 3.9691 3.574
Global Peer CSL ASX 122,798.526 45.770 45.770 16.4100 0.981
Global Peer CELGENE CORP NASDAQ 77,982.503 19.274 13.262 6.4518 -
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer BIOGEN INC NASDAQ 53,075.210 11.979 9.837 3.7922 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 51,918.585 24.766 24.218 9.8829 -
Global Peer ILLUMINA INC NASDAQ 43,365.000 52.500 44.568 9.7691 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,800.557 15.464 17.629 3.5985 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,122.932 310.862 16.407 2.3269 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), SINO BIOPHARM (HKEx), SEATTLE GENETICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), EXELIXIS INC (NASDAQ), GENSCRIPT BIO (HKEx), 3SBIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), UNIQURE N.V. (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), NEXTCURE INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), REGENXBIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), ENANTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CKLIFE SCIENCES (HKEx), ALECTOR INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), OPKO HEALTH INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), VIVA BIOTECH (HKEx), KARYOPHARM THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), RUBIUS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), OMEROS CORP (NASDAQ), CORTEXYME INC (NASDAQ), MESOBLAST LTD (ASX), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ASCLETIS-B (HKEx), VIKING THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RETROPHIN INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), PROGENICS PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ESSEX BIO-TECH (HKEx), UROGEN PHARMA LTD (NASDAQ), AGENUS INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), KADMON HLDGS INC (NYSE), RIGEL PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), ARDELYX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), PUMA BIOTECHNOLOGY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), LEE'S PHARM (HKEx), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), MEDICINOVA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), COMPUGEN (NASDAQ), PDL BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PERSONALIS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), CASI PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), GERON CORP (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), DPHARMA (Bursa), GALECTIN THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), KAMADA (NASDAQ), XOMA CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ATHERSYS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ELOXX PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), BBI LIFE SCI (HKEx), NABRIVA THERAPEUTICS PLC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), ENZO BIOCHEM INC (NYSE), RESAPP HEALTH LIMITED (ASX), FIVE PRIME THERAPEUTICS (NASDAQ), UNI-BIO GROUP (HKEx), JOUNCE THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SESEN BIO INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), PHYLOGICA LIMITED (ASX), AVALON GLOBOCARE CORP (NASDAQ), NANTKWEST INC (NASDAQ), NOVAVAX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), VTV THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VERASTEM INC (NASDAQ), VACCINEX INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), ARAVIVE INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFLARX N V (NASDAQ), TREVENA INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), IDERA PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IMUGENE LIMITED (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ORTHOCELL LIMITED (ASX), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CT ENTERPRISE (HKEx), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), PORT (SET), SURFACE ONCOLOGY INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), BIONOMICS LTD (ASX), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), NOVITA HEALTHCARE LTD (ASX), EVOGENE LTD (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), REGENT PACIFIC (HKEx), LEAP THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), BIOTRON (ASX), ZAFGEN INC (NASDAQ), MEMPHASYS LTD (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), RHINOMED LIMITED (ASX), CONTRAFECT CORP (NASDAQ), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), MIRAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), SIERRA ONCOLOGY INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SENESTECH INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), IMMURON LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), SOPHIRIS BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BIOCEPT INC (NASDAQ), TOCAGEN INC (NASDAQ), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), DARE BIOSCIENCE INC (NASDAQ), ADALTA LTD (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CELLMID LIMITED (ASX), TROVAGENE INC (NASDAQ), VAXART INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), BENITEC BIOPHARMA LTD (ASX), OCUGEN INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), MEGASUN (Bursa), HAO WEN HLDGS (HKEx), ADVAXIS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), BIOXYNE LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), IMMUTEP LTD (ASX), CLEVELAND BIOLABS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MEDIBIO LIMITED (ASX), CYCLACEL PHARMA IN (NASDAQ), TBG DIAGNOSTICS LTD (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), NANOLLOSE LTD (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), SENECA BIOPHARMA INC (NASDAQ), BPH ENERGY LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SPHERIX INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.140
-16.10 %
10 Days --0.105
-12.59 %
20 Days --0.219
-23.09 %
Medium Term Return 3 Months --0.290
-28.44 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.724 - 1.180 Change From 1 Year Low +0.006 % Change From 1 Year Low (%) +0.88
Change From 1 Year High -0.450 % Change From 1 Year High (%) -38.14
2 Years Range 0.724 - 1.180 Change From 2 Years Low +0.006 % Change From 2 Years Low (%) +0.88
Change From 2 Years High -0.450 % Change From 2 Years High (%) -38.14
5 Years Range 0.724 - 1.180 Change From 5 Years Low +0.006 % Change From 5 Years Low (%) +0.88
Change From 5 Years High -0.450 % Change From 5 Years High (%) -38.14
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Alameda, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
11 Nov 2019 0.839 0.839 0.724 0.730 543,011 -
08 Nov 2019 0.820 0.850 0.795 0.796 339,839 -
07 Nov 2019 0.822 0.840 0.822 0.840 116,501 -
06 Nov 2019 0.844 0.866 0.821 0.823 191,979 -
05 Nov 2019 0.830 0.872 0.781 0.870 479,576 -
04 Nov 2019 0.750 0.830 0.738 0.830 582,948 -
01 Nov 2019 0.800 0.818 0.770 0.787 300,840 -
31 Oct 2019 0.825 0.846 0.780 0.780 692,965 -
30 Oct 2019 0.835 0.850 0.800 0.838 182,122 -
29 Oct 2019 0.860 0.890 0.813 0.835 319,974 -
28 Oct 2019 0.850 0.890 0.850 0.860 354,378 -
25 Oct 2019 0.910 0.930 0.851 0.852 805,086 -
24 Oct 2019 0.960 0.990 0.930 0.937 182,912 -
23 Oct 2019 0.980 1.010 0.940 0.961 242,982 -
22 Oct 2019 0.965 0.990 0.931 0.958 178,239 -
21 Oct 2019 1.000 1.010 0.960 0.970 278,310 -
18 Oct 2019 0.930 0.990 0.930 0.978 309,465 -
17 Oct 2019 1.000 1.000 0.960 0.960 141,829 -
16 Oct 2019 0.950 1.020 0.920 1.010 376,667 -
15 Oct 2019 0.950 0.960 0.930 0.949 242,989 -
14 Oct 2019 0.960 0.970 0.920 0.930 231,697 -
11 Oct 2019 0.950 0.970 0.940 0.940 227,104 -
Summary
Current 2 Weeks
(29 Oct 2019 to 11 Nov 2019)
0.860 0.890 0.724 0.730 3,749,755 -
Previous 2 Weeks
(15 Oct 2019 to 28 Oct 2019)
0.950 0.960 0.724 0.860 3,112,857 -
4 Weeks from
(17 Sep 2019 to 14 Oct 2019)
1.010 1.030 0.724 0.930 6,688,941 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.